You are here

Bridion

Merck’s Bridion Could Face Generic Pressure from Hikma Ahead of Patent Expiry Date

BioSpace

Tue, 02/27/24 - 10:18 am

muscle relaxants

Merck secures Bridion patent protection through January 2026

BioSpace

Thu, 06/15/23 - 10:16 am

muscle relaxant reversal

Merck finally adds postsurgery med Bridion to its U.S. lineup. Will hospital buyers step up?

Fierce Pharma Marketing

Wed, 12/16/15 - 07:57 pm

FDA approves Merck drug to reverse effects of muscle relaxants

Yahoo/Reuters

Tue, 12/15/15 - 04:37 pm

FDA bats down Merck's sugammadex in third rejection

Fierce Biotech

Tue, 04/28/15 - 09:01 pm

Drug Development Risk #364: Poorly Run Clinical Trials

Motley Fool

Tue, 09/24/13 - 10:10 am

clinical trials

Vertex Pharmaceuticals

Peregrine Pharmaceuticals

This Drug Needs a Wake-Up Call

Motley Fool

Sat, 03/16/13 - 10:39 am

anesthesia reversal